Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00460642 · ClinicalTrials.gov registry record · NA
GnRH Antagonist to Prepare Recipients for Embryo Transfer
A NA study of Infertility, sponsored by Institute for Human Reproduction (IHR).
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 2
- Study locations
NCT00460642 is a NA study of Infertility that has completed, run by Institute for Human Reproduction (IHR). The registered enrollment target is 130 participants, below the 7,588-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT00460642, a NA study of Infertility, has completed, sponsored by Institute for Human Reproduction (IHR).
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 2
- Study locations
Study Summary
26% of all ART cycles performed in the USA in 2003 (CDC data) are frozen embryo transfers (FET) and transfer of embryos resulting from egg donation (ED) to recipients. The typical protocol used to prepare a recipient for ET involves GnRH agonist (Lupron, Tap Pharmaceuticals) to down regulate the patient. A GnRH antagonist, such as Cetrotide (EMD Serono), is comparable to GnRH agonist and FDA approved to prevent spontaneous ovulation with ART treatment, and its usage decreases significantly the number of injections that the patient receives with treatment. The working hypothesis for this study is that the GnRH antagonist (Cetrotide) can be used instead of an agonist to achieve effective down regulation in FET and ED cycles. Presumably, patients will prefer Cetrotide over Lupron because of the markedly fewer injections required.
Conditions Studied
Interventions
- DRUG GnRH Antagonist (Cetrotide)
Study Locations (2)
Illinois
- Institute for Human Reproduction (IHR) - Chicago
- Institute for Human Reproduction (IHR) - Oakbrook Terrace
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00460642
The ClinicalTrials.gov registry entry for NCT00460642 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,588-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The listed sponsor is Institute for Human Reproduction (IHR), which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which GnRH Antagonist (Cetrotide) is the first listed.
NCT00460642 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00460642 about?
NCT00460642 is a clinical study titled "GnRH Antagonist to Prepare Recipients for Embryo Transfer". 26% of all ART cycles performed in the USA in 2003 (CDC data) are frozen embryo transfers (FET) and transfer of embryos resulting from egg donation (ED) to recipients. The typical protocol used to prepare a recipient for ET involves GnRH agonist (Lupron, Tap Pharmaceuticals) to down regulate the pat...
What is the current status of trial NCT00460642?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2007-01. Estimated completion is 2009-12.
What conditions does trial NCT00460642 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT00460642?
The interventions under investigation include: GnRH Antagonist (Cetrotide) (DRUG).
Who is sponsoring clinical trial NCT00460642?
This trial is sponsored by Institute for Human Reproduction (IHR), which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00460642 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
-
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
RECRUITING · NA
-
Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes
RECRUITING · NA
-
Testicular Tissue Cryopreservation in Children
RECRUITING · NA
-
Sex Selection of Human Spermatozoa
RECRUITING · NA
-
Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.